Account abstraction transforms fixed “private key can do anything” models into programmable systems that enable batching, ...
GenerMotor is a pioneer in high-voltage DC (HVDC) power solutions, specializing in modular, stackable power generation technology designed for the AI and data center era. Collaborating with industry ...
Hi, my name is Christoph, I head the Motorcycle Tyre Team at Continental. I’ve been with the company for quite some time – 13 years in various functions, and now for four years, I’m heading the ...
A new computational method allows modern atomic models to learn from experimental thermodynamic data, according to a ...
Physical artificial intelligence (PAI) is the application of AI and machine learning (ML) algorithms to enable autonomous ...
Imaging-based single-cell physiological profiling holds great potential for uncovering fundamental bacterial cold shock response (CSR) mechanisms, but its application is impeded by severe focus drift ...
Westgold Resources Limited (Westgold or the Company) is pleased to announce that its Board has approved the Final Investment Decision (FID) to expand the Higginsville Processing Hub from 1.6Mtpa to ...
Tycoon2FA has become a leading phishing-as-a-service (PhaaS) platforms, enabling campaigns that reach over 500,000 organizations monthly, prompting Microsoft’s Digital Crimes Unit (DCU) to work with ...
EAE-induced neuroinflammation. Using immuohistochemistry, flow cytometry, and single-cell RNAseq of doublets to interrogate cell-cell interactions, the authors provide solid evidence that macrophages, ...
This experiment relies on MIT to explore the optimal operating conditions for embedded immobilized biological fillers under low temperatures, given the aforementioned characteristics of rural ...
Who is most affected by Salesforce and Block layoffs: In a record-breaking surge for early 2026, the tech industry has already eliminated over 80,000 jobs in the first 40 days of the year, signaling a ...
Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III EXPLORER-HCM trial has demonstrated that the novel cardiac myosin inhibitor ...